Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones,Andreas Wadle,A A Hombach,Eugene Shenderov,Gerhard Held,Eliane Fischer,Sascha Kleber,Natko Nuber,Frank Stenner-Liewen,Stefan Bauer,Andrew J. McMichael,Alexander Knuth,Hinrich Abken,Andreas Hombach,Vincenzo Cerundolo,E. Yvonne Jones,Christoph Renner +16 more
Reads0
Chats0
TLDR
In this article, high-resolution crystal structures of two Fab antibodies in complex with the immunodominant NY-ESO-1(157-165) peptide analogue (SLLMWITQV) presented by HLA-A*0201 and compare them with a TCR recognizing the same pMHC.Abstract:
T-cell interaction with a target cell is a key event in the adaptive immune response and primarily driven by T-cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes. TCR avidity for a given pMHC is determined by number of MHC molecules, availability of coreceptors, and TCR affinity for MHC or peptide, respectively, with peptide recognition being the most important factor to confer target specificity. Here we present high-resolution crystal structures of 2 Fab antibodies in complex with the immunodominant NY-ESO-1(157-165) peptide analogue (SLLMWITQV) presented by HLA-A*0201 and compare them with a TCR recognizing the same pMHC. Binding to the central methionine-tryptophan peptide motif and orientation of binding were almost identical for Fabs and TCR. As the MW "peg" dominates the contacts between Fab and peptide, we estimated the contributions of individual amino acids between the Fab and peptide to provide the rational basis for a peptide-focused second-generation, high-affinity antibody library. The final Fab candidate achieved better peptide binding by 2 light-chain mutations, giving a 20-fold affinity improvement to 2-4 nM, exceeding the affinity of the TCR by 1,000-fold. The high-affinity Fab when grafted as recombinant TCR on T cells conferred specific killing of HLA-A*0201/NY-ESO-1(157-165) target cells. In summary, we prove that affinity maturation of antibodies mimicking a TCR is possible and provide a strategy for engineering high-affinity antibodies that can be used in targeting specific pMHC complexes for diagnostic and therapeutic purposes.read more
Citations
More filters
Journal ArticleDOI
The Basic Principles of Chimeric Antigen Receptor Design
TL;DR: This review focuses on the design ofCARs, including the requirements for optimal antigen recognition and different modalities to provide costimulatory support to targeted T cells, which include the use of second- and third generation CARs, costimulation ligands, chimericcostimulatory receptors, and cytokines.
Journal ArticleDOI
Therapeutic T cell engineering
TL;DR: Engineered T cells are applicable in principle to many cancers, pending further progress to identify suitable target antigens, overcome immunosuppressive tumour microenvironments, reduce toxicities, and prevent antigen escape.
Journal ArticleDOI
Gene-engineered T cells for cancer therapy
TL;DR: Using genetic modification, highly active, self-propagating 'slayers' of cancer cells can be generated.
Journal ArticleDOI
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
TL;DR: The genetic engineering of T cells through the introduction of a chimeric antigen receptor (CAR) allows for generation of tumor‐targeted T cells and most CARs combine antigen‐specificity with T cell activation in a single fusion molecule.
Journal ArticleDOI
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
Marc Cartellieri,Michael Bachmann,Anja Feldmann,Claudia C. Bippes,Slava Stamova,Rebekka Wehner,Achim Temme,Marc Schmitz +7 more
TL;DR: Clinical trials revealed that the adoptive transfer of T cells engineered with first generation CARs represents a feasible concept for the induction of clinical responses in some tumor patients, however, further improvement is required, which may be achieved by second or third generation CAR-engrafted T cells.
References
More filters
Journal ArticleDOI
Coot: model-building tools for molecular graphics.
Paul Emsley,Kevin Cowtan +1 more
TL;DR: CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for X-ray structure solution, structure comparison and analysis, and publication-quality graphics.
Journal ArticleDOI
Refinement of macromolecular structures by the maximum-likelihood method.
TL;DR: The likelihood function for macromolecular structures is extended to include prior phase information and experimental standard uncertainties and the results derived are consistently better than those obtained from least-squares refinement.
Journal ArticleDOI
Likelihood-enhanced fast translation functions.
TL;DR: It is shown here how linear and quadratic Taylor-series expansions and least-squares approximations of the maximum-likelihood translation function lead to likelihood-enhanced translation functions, which can be calculated by FFT and which are more sensitive to the correct translation than the traditional correlation-coefficient fast translation function.
Journal ArticleDOI
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Yao-Tseng Chen,Matthew J. Scanlan,Ugur Sahin,Özlem Türeci,Ali O. Gure,Solam Tsang,Barbara Williamson,Elisabeth Stockert,Michael Pfreundschuh,Lloyd J. Old +9 more
TL;DR: R reverse transcription-PCR analysis showed NY-ESO-1 mRNA expression in a variable proportion of a wide array of human cancers, including melanoma, breast cancer, bladder cancer, prostate cancer, and hepatocellular carcinoma, which indicates that it belongs to an expanding family of immunogenic testicular antigens.
Journal ArticleDOI
Developments in the CCP4 molecular-graphics project
Liz Potterton,Stuart McNicholas,Eugene Krissinel,Jan Gruber,Kevin Cowtan,Paul Emsley,Garib N. Murshudov,Serge X. Cohen,Anastassis Perrakis,Martin E.M. Noble +9 more
TL;DR: CC4 mg is a program designed to meet needs for model building and analysis in a way that is closely integrated with the ongoing development of CCP4 as a program suite suitable for both low- and high-intervention computational structural biology.
Related Papers (5)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin Pule,Barbara Savoldo,G. Doug Myers,G. Doug Myers,Claudia Rossig,Heidi V. Russell,Heidi V. Russell,Gianpietro Dotti,Gianpietro Dotti,M. Helen Huls,Enli Liu,Adrian P. Gee,Adrian P. Gee,Zhuyong Mei,Eric Yvon,Heidi L. Weiss,Hao Liu,Cliona M. Rooney,Cliona M. Rooney,Helen E. Heslop,Helen E. Heslop,Malcolm K. Brenner,Malcolm K. Brenner +22 more
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw,Michael H. Kershaw,Michael H. Kershaw,Jennifer A. Westwood,Jennifer A. Westwood,Linda L. Parker,Gang Wang,Gang Wang,Zelig Eshhar,Sharon Mavroukakis,Donald E. White,John R. Wunderlich,Silvana Canevari,Linda Rogers-Freezer,Clara C. Chen,James Chih-Hsin Yang,Steven A. Rosenberg,Patrick Hwu +17 more